Abstract
Suppressing mineralocorticoid receptor (MR) activity with MR antagonists is therapeutic for chronic skeletal muscle pathology in Duchenne muscular dys......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
